CRVS Corvus Pharmaceuticals, Inc.: institutional ownership and insider trading
177 funds reported holding $1.12B of Corvus Pharmaceuticals, Inc. in their latest 13F filings; in Q2 2026 funds net bought $16.8M, with 35 new positions and 29 funds selling out; over the last 12 months insiders bought $334K and sold $0 on the open market.
CRVS revenue and earnings
- Quarter ended Jun 30, 2026: revenue n/a, net income −$18.0M, EPS -0.19
- Quarter ended Mar 31, 2026: revenue n/a, net income −$13.7M, EPS -0.15
- Quarter ended Dec 31, 2025: revenue n/a, net income −$12.3M, EPS -0.18
- Quarter ended Sep 30, 2025: revenue n/a, net income −$10.2M, EPS -0.12
Famous investors holding CRVS
- Izzy Englander (Millennium Management): $15.7M, 0.0% of the portfolio
- Two Sigma (Two Sigma Investments): $11.7M, 0.0% of the portfolio
- Ken Griffin (Citadel Advisors): $15.6M, 0.0% of the portfolio
- D. E. Shaw (D. E. Shaw & Co.): $1.99M, 0.0% of the portfolio
Largest institutional holders of CRVS
- ORBIMED ADVISORS LLC — $107M
- BlackRock, Inc. (BLK) — $107M
- STATE STREET CORP (STT, STT-PG) — $66.8M
- PRICE T ROWE ASSOCIATES INC /MD/ — $56.6M
- VANGUARD CAPITAL MANAGEMENT LLC — $49.2M
- ADAMS STREET PARTNERS LLC — $48.9M
- Vivo Capital, LLC — $41.9M
- WELLINGTON MANAGEMENT GROUP LLP — $40.8M
- PERCEPTIVE ADVISORS LLC — $39.9M
- Deep Track Capital, LP — $37.2M
Recent CRVS insider trades
- Jun 11, 2026: Moore David Scott bought 21,700 shares ($250K)
- May 18, 2026: Miller Richard A Md bought 6,932 shares ($83.5K)
- Jun 27, 2025: Orbimed Advisors Llc sold 1,176,332 shares ($4.89M)
- Jun 27, 2025: Thompson Peter A. sold 1,176,332 shares ($4.89M)
5%+ owners
- BlackRock, Inc.: 7.5% (Schedule 13G/A, filed Jul 27, 2026)
- Sirenia Capital Management LP: 7.5% (Schedule 13G, filed May 15, 2026)
- STATE STREET CORPORATION: 5.3% (Schedule 13G, filed Aug 7, 2026)
Who owns the most CRVS stock?
The largest institutional holders of Corvus Pharmaceuticals, Inc. in the latest 13F filings are ORBIMED ADVISORS LLC ($107M), BlackRock, Inc. (BLK) ($107M), STATE STREET CORP (STT, STT-PG) ($66.8M).
Are insiders buying or selling CRVS?
Over the last 12 months insiders bought $334K and sold $0 of Corvus Pharmaceuticals, Inc. stock on the open market (SEC Form 4).
Which famous investors own CRVS?
Izzy Englander, Two Sigma, Ken Griffin, D. E. Shaw.
Which ETFs hold CRVS?
7 ETFs and mutual funds hold it among their top 100 positions, including XBI, IWC, LFSC, IDNA.